echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Shanghai Suspends Xinfeng Pharmaceutical's Procurement Qualification for Luotongding Sulfate Injection for 1 Year

    Shanghai Suspends Xinfeng Pharmaceutical's Procurement Qualification for Luotongding Sulfate Injection for 1 Year

    • Last Update: 2022-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 24, 2022, the Shanghai Pharmaceutical Centralized Tendering and Procurement Administration issued a notice on the suspension of the procurement qualification of Luotongdine Sulfate Injection produced by Guangdong Xinfeng Pharmaceutical Co.


    The notice shows that in accordance with the relevant provisions of the "Notice on the Full Implementation of Public Negotiated Procurement of Drugs on the Internet" (Hu Yao Shi [2018] No.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.